Medical and Pharmaceutical MIT continues advancing ‘PlasmoSniff’ pneumonia breath test The prestigious school is one of a select few active with breath sampling tech for this infection Rowan Dunne4 days ago
AI and Autonomy Ainos deploys ‘AI Nose’ tech for environmental monitoring in Taiwan ER These devices have already proven their worth for environmental monitoring in advanced manufacturing Rowan DunneJune 19, 2026
Medical and Pharmaceutical Micro-X and University of Sydney undertake mini lung CT scanner research They have secured AUD$1.9 million for their project Rowan DunneJune 18, 2026
AI and Autonomy Five technologies moving from science fiction to reality: A Mugglehead roundup The goal is to solve longstanding problems that have resisted traditional approaches Joseph MortonJune 12, 2026
Medical and Pharmaceutical Liquid chromatography-mass spectrometry proves its worth in lung cancer screening It is highly impactful for blood draws and breath samples Rowan DunneJune 12, 2026
Medical and Pharmaceutical BioMark expands lung cancer screening portfolio with patented urine test It is one of a select few pursuing this variety of diagnostics Rowan DunneJune 10, 2026
Medical and Pharmaceutical Lung cancer innovations showcased at ASCO 2026 as researchers pursue earlier detection Lung cancer is the world's deadliest cancer Joseph MortonJune 9, 2026
Medical and Pharmaceutical AI-powered blood test promises lung cancer detection 5 years in advance British scientists used the biopsy to detect a 14-protein blood signature linked to the disease Rowan DunneJune 4, 2026
Medical and Pharmaceutical Scientists develop microneedle tattoo that detects melanoma in its earliest stages Doctors still rely heavily on visual inspections followed by biopsies to confirm whether suspicious skin lesions are cancerous Joseph MortonJune 3, 2026
Medical and Pharmaceutical International research surge highlights asbestos health crisis It's being overlooked in lung cancer screening, causing a record number of legal claims and may be deadlier than once thought Rowan DunneJune 2, 2026